Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NICE approves raft of new drugs

  • Comment

Drugs for overactive bladder, type 2 diabetes and preventing blood clots have been approved for use by the NHS in England and Wales.

The National Institute for Health and Care Excellence has recommended mirabegron (Betmiga) as an option for treating the symptoms of overactive bladder and also rivaroxaban (Xarelto) as an option for treating pulmonary embolism and preventing recurrent deep vein thrombosis and PE.

Meanwhile, in a further technology appraisal, NICE said dapagliflozin (Forxiga) was recommended as an option for treating type 2 diabetes in combination with metformin or insulin.


Are you able to Speak Out Safely? Sign our petition to put pressure on your trust to support an open and transparent NHS.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs